Invokana

Invokana (canagliflozin) is a blood sugar drug that’s prescribed to type 2 diabetes patients. It belongs to the SGLT2 inhibitor family, and is now under scrutiny due to the severe, life-threatening side effects patients report to the FDA. In addition, several post-market studies now show that Invokana can cause the following health problems:

• More than doubles your risk for suffering foot, toe and lower-limb amputations
• Significantly increases risk for chronic, severe urinary tract infections
• Cardiovascular events, including heart attacks, strokes and congestive heart failure
• Diabetic acidosis, also known as ketoacidosis, which is common amongst type 1 diabetics, but rare in type 2 sufferers (this complication requires hospitalization to treat and can result in coma and even death)
• Kidney injuries, including renal failure